Stock Events

Stock Events

Alterola Biotech 

$0.01
7
+$0+0% Monday 20:00

Statistics

Day High
0.2
Day Low
0.2
52W High
0.2
52W Low
0
Volume
190
Avg. Volume
9,126
Mkt Cap
7.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0003

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-4.75MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABTI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Corbus Pharmaceuticals focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases, using cannabinoid receptor agonists similar to Alterola's approach.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, posing competition to Alterola's ambitions in the cannabinoid market.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation is a world-leading diversified cannabis and cannabinoid-based consumer product company, competing across several of Alterola's target markets.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is engaged in the production and distribution of medical cannabis, directly competing with Alterola Biotech in the cannabinoid product space.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group is an innovative global cannabinoid company, with operations and products that compete with Alterola Biotech's offerings in the cannabinoid sector.

About

Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
Show more...
CEO
Mr. David John Hitchcock O.B.E.
Employees
1
Country
US
ISIN
US02152V1035

Listings

OTC Link
US
ABTI

0 Comments

Share your thoughts

FAQ

What is Alterola Biotech stock price today?▼
The current price of ABTI is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Alterola Biotech stock price performance more closely on the chart.
What is Alterola Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alterola Biotech stocks are traded under the ticker ABTI.
What is Alterola Biotech market cap?▼
Today Alterola Biotech has the market capitalization of 7.44M
What were Alterola Biotech earnings last quarter?▼
ABTI earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alterola Biotech revenue for the last year?▼
Alterola Biotech revenue for the last year amounts to 0 USD.
What is Alterola Biotech net income for the last year?▼
ABTI net income for the last year is -4.75M USD.
How many employees does Alterola Biotech have?▼
As of April 03, 2026, the company has 1 employees.
In which sector is Alterola Biotech located?▼
Alterola Biotech operates in the Health Care sector.
When did Alterola Biotech complete a stock split?▼
The last stock split for Alterola Biotech was on August 26, 2010 with a ratio of 10:1.
Where is Alterola Biotech headquartered?▼
Alterola Biotech is headquartered in Birkenhead, US.